DrugPatentWatch

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Tradename: A-HYDROCORT

Summary for Tradename: A-HYDROCORT

Patents:0
Applicants:2
NDAs:10
drug
patent expirations by year for
 A-HYDROCORT

Clinical Trials for: A-HYDROCORT

Contribution of Salivary Cortisol in the Detection of Infra-clinic Cortisol Adenoma (ACIC)
Status: Terminated Condition: Obesity

An Investigational Study of Hydrocortisone
Status: Completed Condition: Adrenal Insufficiency

Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia
Status: Completed Condition: Congenital Adrenal Hyperplasia; 21-Hydroxylase Deficiency; Adrenogenital Syndrome

Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease
Status: Not yet recruiting Condition: Addison Disease

Sensitivity of Short and Long Allele Carriers of the 5-HTTLPR to Environmental Threat Post Hydrocortisone Administration
Status: Recruiting Condition: Major Depressive Disorder; Anxiety Disorders

Adherence to Topical Hydrocortisone 17-Butyrate 0.1% (Locoid®) Using Different Vehicles in Adults With Atopic Dermatitis
Status: Active, not recruiting Condition: Atopic Dermatitis

Hydrocortisone Replacement in Patients With Secondary Adrenal Insufficiency (SUPREME CORT)
Status: Completed Condition: Adrenal Insufficiency

Pharmacokinetics of Hydrocortisone After Subcutaneous Administration in Chronic Adrenal Insufficiency
Status: Completed Condition: Primary Adrenal Insufficiency

Effects of Hydrocortisone, Melatonin, and Placebo on Jet Lag
Status: Completed Condition: Jet Lag Syndrome

Once-daily Oral Modified Release Hydrocortisone in Patients With Adrenal Insufficiency
Status: Completed Condition: Adrenal Insufficiency

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott
A-HYDROCORT
hydrocortisone sodium succinate
INJECTABLE;INJECTION085928Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
Abbott
A-HYDROCORT
hydrocortisone sodium succinate
INJECTABLE;INJECTION089577Apr 11, 1989DISCNNo<disabled><disabled>
Abbott
A-HYDROCORT
hydrocortisone sodium succinate
INJECTABLE;INJECTION089578Apr 11, 1989DISCNNo<disabled><disabled>
Abbott
A-HYDROCORT
hydrocortisone sodium succinate
INJECTABLE;INJECTION089579Apr 11, 1989DISCNNo<disabled><disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc